Dunn, Christopher J.; Foster, Rachel H. - In: PharmacoEconomics 16 (1999) 6, pp. 711-741
Abciximab is a monoclonal antibody fragment that inhibits platelet aggregation through antagonism of glycoprotein IIb … abciximab, as an adjunct to aspirin and heparin, to reduce by around one-third to one-half the incidence of ischaemic … risk, and abciximab also reduces complications in patients undergoing coronary stenting, although the drug does not appear …